By Sheri Kasprzak
New York, May 16 - Medivation, Inc. is gearing up to close a $14.25 million private placement of its stock.
The deal includes 3 million shares at $4.75 each and is scheduled to wrap up on May 18.
The shares are being sold under Medivation's shelf registration.
Emerging Growth Equities, Ltd. is the placement agent.
Medivation, based in San Francisco, is a biopharmaceutical company focused on treatments for Alzheimer's and Huntington's disease, as well as prostate cancer.
| Issuer: | Medivation, Inc.
|
| Issue: | Stock
|
| Amount: | $14.25 million
|
| Shares: | 3 million
|
| Price: | $4.75
|
| Warrants: | No
|
| Placement agent: | Emerging Growth Equities, Ltd.
|
| Announcement date: | May 16
|
| Settlement date: | May 18
|
| Stock symbol: | Amex: MDV
|
| Stock price: | $4.93 at close May 16
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
